NEW YORK, May 28 - Spotfire and Rosetta Biosoftware said today they will integrate their DecisionSite and Resolver technologies.
Under the three-year deal, current and future customers who subscribe to the platforms will be able to use both products simultaneously.
The integration will be available as early as July at no additional cost to customers who use both tools. It will take place either over the Internet or through an installation process, said David Butler, vice president of product strategy and marketing at Spotfire.
Click here for more information.